RN7SL329P

Across TCGA pan-cancer cohorts, RN7SL329P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL329P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RN7SL329P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL329P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

STAD, BRCA, and LIHC are the cancer types where RN7SL329P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL329P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.445	.003	4	view →
BRCA	Female	All	+0.240	.011	4	view →
LIHC	All	All	+0.083	.002	3	view →
THCA	All	II,III,IV	−0.109	.016	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL329P–STAD

Open the STAD breakdown →